Journal of Medicinal Chemistry · 2022 · 27 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyAntimicrobial ResistanceDrug DesignDrug DiscoveryAmino Acid ChemistryAntibacterial AgentsAntibacterial PharmacologyAntimicrobial PeptidesPeptide ChemistryPeptide Drug DiscoveryAntibacterial PeptidesAntimicrobial Peptide ActivityBicyclic Peptide DesignCationic Antimicrobial PeptidesCyclized PeptidesPeptide CyclizationProteolytic StabilityProteolytic Stability Control
Antimicrobial peptides (AMPs) have attracted great attention as next generation antibiotics for the treatment of multidrug-resistant (MDR) bacterial infections. Poor proteolytic stability has however undermined clinical applications of AMPs. A novel peptide cyclization approach is described to enhance the in vivo antibacterial activity of AMPs. Bicyclic antimicrobial peptides were synthesized by cross-linking the ε-amino groups of three lysine residues with a 1,3,5-trimethylene benzene spacer. In a proof of principal study, four bicyclic peptides were synthesized from the cationic AMP OH-CM6. One bicyclic peptide retained strong antimicrobial activity and low toxicity but exhibited a prolonged half-life in serum. Antibacterial activity was consequently improved in vivo without renal or hepato-toxicity. The novel peptide cyclization approach represents an important tool for enhancing AMP proteolytic stability for improved treatment of bacterial infection.
23
Donald P. Levine · Clinical Infectious Diseases · 2005 · 831 citations · Full text
Antimicrobial peptides stage a comeback
Jeffrey L. Fox · Nature Biotechnology · 2013 · 517 citations